Drug intelligence / Profile preview

Ikon

Development stage: Unknown
Administration: Topical

Overview

Ikon is an insecticide used in public health programs for malaria control. It is applied through spraying to reduce the population of malaria-carrying vectors, thereby preventing the spread of Plasmodium falciparum malaria in communities. Its use has been shown to be effective in significantly reducing malaria morbidity and mortality.

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on Ikon.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ikon.

Explore the full profile